Metformin Synergistically Potentiates the Antitumor Effects of Imatinib in Colorectal Cancer Cells

Metformin is the most commonly prescribed anti-diabetic drug with relatively minor side effect. Substantial evidence has suggested that metformin is associated with decreased cancer risk and anticancer activity against diverse cancer cells. The tyrosine kinase inhibitor imatinib has shown powerful a...

Full description

Saved in:
Bibliographic Details
Published in:Dev Reprod
Main Authors: Lee, Jaeryun, Park, Deokbae, Lee, Youngki
Format: Artigo
Language:Inglês
Published: The Korean Society of Developmental Biology 2017
Subjects:
Original Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5532306/
https://ncbi.nlm.nih.gov/pubmed/28785735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12717/DR.2017.21.2.139
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items